Regular Article
Toxicity of nitrous oxide

https://doi.org/10.1053/bean.2002.0264Get rights and content

Abstract

Nitrous oxide interacts with vitamin B12 resulting in selective inhibition of methionine synthase, a key enzyme in methionine and folate metabolism. Thus, nitrous oxide may alter one-carbon and methyl-group transfer most important for DNA, purine and thymidylate synthesis. Long-term exposure to high concentrations of nitrous oxide may cause megaloblastic bone-marrow depression and neurological symptoms. Exposure to higher doses for less than 6 hours, as in clinical anaesthesia, are considered harmless. Recent studies seem to suggest a correlation between nitrous oxide anaesthesia and hyperhomocysteinaemia which is accepted to be an independent risk factor for coronary artery disease. As for today, available data do not support the notion that exposure to trace amounts of nitrous oxide is associated with impaired fertility or an increased risk of developing cancer. Emission of nitrous oxide from medical use is estimated to contribute less than 0·05% to total annual greenhouse gas emission.

References (80)

  • RJ Amos et al.

    Prevention of nitrous oxide-induced megaloblastic changes in bone marrow using folinic acid

    British Journal of Anaesthesiology

    (1984)
  • H CA Lassen et al.

    Treatment of tetanus with curarisation, general anaesthesia, and intratracheal positive-pressure ventilation

    Lancet

    (1954)
  • M JW Sando et al.

    Bone-marrow depression following treatment of tetanus with protracted nitrous-oxide anaesthesia

    Lancet

    (1958)
  • AL Stead et al.

    A severe case of tetanus showing interesting features

    British Journal of Anaesthesiology

    (1962)
  • P Wilson et al.

    Bone-marrow depression in tetanus. Report of a fatal case

    Lancet

    (1956)
  • RB Layzer

    Myeloneuropathy after prolonged exposure to nitrous oxide

    Lancet

    (1978)
  • L Gutmann et al.

    Nitrous oxide-induced myeloneuropathy: report of cases

    Journal of the American Dental Association

    (1981)
  • L Gutmann et al.

    Nitrous oxide-induced myelopathy-neuropathy: potential for chronic misuse by dentists

    Journal of the American Dental Association

    (1979)
  • H Butzkueven et al.

    Nitrous oxide myelopathy in an abuser of whipped cream bulbs

    Journal of Clinical Neuroscience

    (2000)
  • M Logan et al.

    Anaesthesia and the ozone layer

    British Journal of Anaesthesiology

    (1989)
  • JS Sprigge

    Sir Humphry Davy: his researches in respiratory physiology and his debt to Antoine Lavoisier

    Anaesthesia

    (2002)
  • H Davy

    Researches, Chemical and Philosophical Chiefly Concerning Nitrous Oxide or Diphlogisticated Air, and its Respiration

    (1800)
  • MC Jacob et al.

    Why did Humphry Davy and associates not pursue the pain-alleviating effects of nitrous oxide?

    Journal of the History of Medicine and Allied Sciences

    (2002)
  • GB Smith et al.

    Gardner Quincy Colton: pioneer of nitrous oxide anesthesia

    Anesthesia & Analgesia

    (1991)
  • H Sund Kristensen et al.

    Risus sardonicus and laughing gas – when nitrous oxide lost its innocence

    Acta Anaesthesiologica Scandinavica

    (1994)
  • EI Eger et al.

    Clinical pharmacology of nitrous oxide: an argument for its continued use

    Anesthesia & Analgesia

    (1990)
  • A Rothhammer

    Lachgas heute – eine klinische Wertung auf dem Boden der Literatur

    Anasthesiol Intensivmed Notfallmed Schmerzther

    (2002)
  • J Schulte am Esch et al.

    Zur Diskussion über das Ende der Lachgas-Ära in Deutschland – emotionaled Meinungsbild oder zwingende Notwendigkeit?

    Anasthesiol Intensivmed Notfallmed Schmerzther

    (2001)
  • O Stenqvist et al.

    Nitrous oxide: an ageing gentleman

    Acta Anaesthesiologica Scandinavica

    (2001)
  • I Chanarin

    Cobalamins and nitrous oxide: a review

    Journal of Clinical Pathology

    (1980)
  • R GS Banks et al.

    Reaction of gases in solutions. Part III. Some reactions of nitrous oxide with transition-metal complexes

    Journal of the Chemical Society (A)

    (1968)
  • H Nilsson-Ehle

    Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy

    Drugs and Aging

    (1998)
  • W Herrmann et al.

    Total homocysteine, vitamin B(12), and total antioxidant status in vegetarians

    Clinical Chemistry

    (2001)
  • B Fowler

    Genetic defects of folate and cobalamin metabolism

    European Journal of Pediatrics

    (1998)
  • R Deacon et al.

    Vitamin B12, folate and nitrous oxide

    Medical Laboratory Sciences

    (1982)
  • H Kondo et al.

    Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activities of both mammalian cobalamin-dependent enzymes in rats

    Journal of Clinical Investigation

    (1981)
  • J Schneede et al.

    Biological and environmental determinants of plasma homocysteine

    Seminars in Thrombosis and Hemostasis

    (2000)
  • J Schneede et al.

    Methylmalonic acid and homocysteine in plasma as indicators of functional cobalamin deficiency in infants on macrobiotic diets

    Pediatric Research

    (1994)
  • SH Mudd et al.

    The natural history of homocystinuria due to cystathionine beta-synthase deficiency

    American Journal of Human Genetics

    (1985)
  • Cited by (128)

    • Inhalants

      2021, Critical Care Clinics
      Citation Excerpt :

      N2O causes nausea, vomiting, intoxication, irritant effects, and death from asphyxiation.83 Bone marrow function can be impaired.84 Chronic use causes irreversible oxidation of the cobalt ion of cyanocobalamin (vitamin B12).85

    View all citing articles on Scopus
    f1

    Tel.: +49 30 450 551001; Fax: +49 30 450 551901. E-mail address: [email protected] (J.weimann).

    View full text